
- /
- Supported exchanges
- / US
- / IRON.NASDAQ
Disc Medicine Inc. (IRON NASDAQ) stock market data APIs
Disc Medicine Inc. Financial Data Overview
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. It also develops preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Disc Medicine Inc. data using free add-ons & libraries
Get Disc Medicine Inc. Fundamental Data
Disc Medicine Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -138 054 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-07
- EPS/Forecast: -1.0738
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Disc Medicine Inc. News

Disc medicine CFO Franchi sells $119k in shares
Jean M. Franchi, Chief Financial Officer of Disc Medicine, Inc. (NASDAQ:IRON), sold 2,031 shares of common stock on July 17, 2025, at a price of $59.00, totaling $119,829. The transaction occurred nea...


Commodity Roundup: Gold rises as tariff worries lift safe-haven demand ahead of key inflation data
[gold bars on brown background] Sanlad/iStock via Getty Images Gold prices (XAUUSD:CUR [https://seekingalpha.com/symbol/XAUUSD:CUR]) edged higher on Tuesday as concerns over the impact of US tariffs ...

Disc medicine CFO Franchi sells $115k in stock
Jean M. Franchi, Chief Financial Officer of Disc Medicine, Inc. (NASDAQ:IRON), a biotechnology company with a market capitalization of $1.99 billion, sold 2,000 shares of common stock on July 10, 2025...

Disc Medicine appoints Nadim Ahmed to board of directors
WATERTOWN, Mass. - Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company with a market capitalization of $1.97 billion, has appointed Nadim Ahmed to its Board of Directors, acc...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.